Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Elvira Sanz named next president of Farmaindustria

Will lead Spanish pharma industry body for the new two years

Pfizer Spain Farmaindustria Elvira SanzSpanish pharmaceutical industry body Farmaindustria has selected Pfizer Spain's president and CEO Elvira Sanz to serve as its new president.

She will serve a two-year term and replaces Ferrer Grupo CEO Jordi Rementol, who took office in 2010.

Sanz has worked in the pharmaceutical industry for nearly 25 years, holding increasingly senior roles at Abelló, MSD, Roche and Cyanamid.

She became directorate general at Wyeth Spain in 2000 and was named president and CEO of Pfizer Spain in 2009.

Sanz takes up her new role at Farmaindustria at a time of increasing difficulties for the Spanish pharma industry, which has been hit hard by a series of government cost-containment measures and unpaid bills.

26th October 2012

From: Research, Sales, Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Succinct Medical Communications

At Succinct our goal is to motivate and inspire our audiences - by always thinking beyond communications and education. Our...

Latest intelligence

Is telehealth delivering on its promises?
Using new digital technologies to help patients see their doctors online and not need to attend their surgery can help save time and money - but just how well is...
Channel purpose, change lives
GCI Health's Laura Starr on the power of creativity in health and wellness, all founded upon authentic brand purpose....
Wearables: the tangible product of the patient revolution
As the relationship between the patient and his doctor evolve, we look at how new technology is playing its part...

Infographics